LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 52 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $675,106 | +89.2% | 121,422 | +149.8% | 0.00% | – |
Q2 2023 | $356,805 | +141.4% | 48,611 | +29.2% | 0.00% | – |
Q1 2023 | $147,811 | +24.4% | 37,611 | 0.0% | 0.00% | – |
Q4 2022 | $118,851 | -12.0% | 37,611 | 0.0% | 0.00% | – |
Q3 2022 | $135,000 | +16.4% | 37,611 | 0.0% | 0.00% | – |
Q2 2022 | $116,000 | -40.5% | 37,611 | -0.0% | 0.00% | – |
Q1 2022 | $195,000 | -20.7% | 37,624 | -26.0% | 0.00% | – |
Q4 2021 | $246,000 | -51.8% | 50,850 | -11.2% | 0.00% | -100.0% |
Q3 2021 | $510,000 | +233.3% | 57,275 | +237.1% | 0.00% | – |
Q2 2021 | $153,000 | -44.8% | 16,993 | 0.0% | 0.00% | – |
Q1 2021 | $277,000 | – | 16,993 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,273,221 | $11,069,000 | 0.66% |
Integral Health Asset Management, LLC | 30,000 | $146,000 | 0.04% |
FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $3,923,000 | 0.02% |
Orbimed Advisors | 113,500 | $554,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $339,000 | 0.01% |
Alyeska Investment Group, L.P. | 62,500 | $305,000 | 0.00% |
Veritable, L.P. | 20,534 | $100,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 225,557 | $1,092,000 | 0.00% |
FMR LLC | 1,515,583 | $7,336,000 | 0.00% |
CITIGROUP INC | 200,000 | $968,000 | 0.00% |